Biotech / MedTech
Nourish Ingredients partners CABIO Biotech for global commercial scale of precision fermentation fats
In partnership with Chinese biotechnology company CABIO Biotech, Australian animal-free fats and precision fermentation startup Nourish Ingredients has successfully completed its first commercial production of Tastilux®, its potent meaty fat.
HKUST partners SIIC to launch Hong Kong biotechnology fund
The Hong Kong University of Science and Technology (HKUST) and Shanghai Industrial Investment (Holdings) Co., Ltd. (SIIC) have announced the establishment of the Hong Kong Biotechnology Fund (HKBF) to foster innovation in the life sciences sector.
Chitose Bio Evolution raises $49M through third-party allotment for expansion
Chitose Bio Evolution, a Singapore-based biotech firm and the headquarters of Chitose Group, has announced the issuance of new shares of JPY 7.3 billion ($49 million) through a third-party allotment for expansion.
Accelerating new drug development with AI in APAC
Clinical trials and the process of new drug development generate some of the highest-quality data in the world. The use of #AI in these represents a transformative shift that promises to make studies in drug development more efficient, accurate, and patient-centric.
Singapore’s Ignition AI Accelerator partners Pfizer to advance biopharma sector with AI
Ignition AI Accelerator, a collaborative initiative between NVIDIA, Tribe, and Digital Industry Singapore (DISG), has announced a a strategic partnership with global biopharmaceutical leader Pfizer to advance biopharma sector with artificial intelligence (AI).
Shenzhen-based PAM2L Biotechnologies plans new round of funding to expand capabilities
PAM2L Biotechnologies is one of the finalists of Fund At First Pitch at BEYOND Expo 2024.
Hong Kong’s biotech firm Geb Impact aims to raise funds as it eyes further expansion
Geb Impact is one of the finalists of Fund at first pitch at BEYOND Expo 2024.
When “self-driving” enters the laboratory
#AI allows humans to conduct research and achieve innovation in a more efficient, more cost-effective, and more systematic way. However, looking back at the history of human inventions, some of the most representative inventions stem not only from systematic research but also from human curiosity, keen observation, and serendipity.
Engineering biology is expected to disrupt all industries, says Capgemini
Engineering biology is expected to disrupt all industries, as all organizations surveyed in Singapore believe biosolutions will create a major disruption in their industry in the next ten years, Capgemini Research Institute said in a report on Monday.
Singapore’s CHITOSE Group raises $6.2M from Japan’s SMBC
Singapore-based biotech firm Chitose Bio Evolution Pte. Ltd. has announced the issuance of new shares of JPY 1 billion ($6.2 million) through a third-party allotment to Sumitomo Mitsui Banking Corporation (SMBC).
